• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞激活基因-3(CD223)诱导树突状细胞的成熟与激活。

Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).

作者信息

Andreae Susanne, Piras Fabienne, Burdin Nicolas, Triebel Frédéric

机构信息

Laboratoire d'Immunologie des Tumeurs, Université Paris-Sud, Chatenay Malabry, France.

出版信息

J Immunol. 2002 Apr 15;168(8):3874-80. doi: 10.4049/jimmunol.168.8.3874.

DOI:10.4049/jimmunol.168.8.3874
PMID:11937541
Abstract

Lymphocyte activation gene-3 (LAG-3) is an MHC class II ligand expressed on activated T and NK cells. A LAG-3Ig fusion protein has been used in mice as an adjuvant protein to induce antitumor responses and specific CD8 and CD4 Th1 responses to nominal Ags. In this work we report on the effect of LAG-3Ig on the maturation and activation of human monocyte-derived dendritic cells (DC). LAG-3Ig binds MHC class II molecules expressed in plasma membrane lipid rafts on immature human DC and induces rapid morphological changes, including the formation of dendritic projections. LAG-3Ig markedly up-regulates the expression of costimulatory molecules and the production of IL-12 and TNF-alpha. Consistent with this effect on DC maturation, LAG-3Ig disables DC in their capacity to capture soluble Ags. These events are associated with the acquisition of professional APC function, because LAG-3Ig increases the capacity of DC to stimulate the proliferation and IFN-gamma response by allogeneic T cells. These effects were not observed when using ligation of MHC class II by specific mAb. Class II-mediated signals induced by a natural ligand, LAG-3, lead to complete maturation of DC, which acquire the capacity to trigger naive T cells and drive polarized Th1 responses.

摘要

淋巴细胞激活基因-3(LAG-3)是一种在活化的T细胞和NK细胞上表达的MHC II类配体。一种LAG-3Ig融合蛋白已在小鼠中用作佐剂蛋白,以诱导抗肿瘤反应以及对名义抗原的特异性CD8和CD4 Th1反应。在这项工作中,我们报告了LAG-3Ig对人单核细胞衍生的树突状细胞(DC)成熟和活化的影响。LAG-3Ig与未成熟人DC质膜脂筏中表达的MHC II类分子结合,并诱导快速的形态变化,包括树突状突起的形成。LAG-3Ig显著上调共刺激分子的表达以及IL-12和TNF-α的产生。与对DC成熟的这种作用一致,LAG-3Ig使DC捕获可溶性抗原的能力丧失。这些事件与专业抗原呈递细胞功能的获得有关,因为LAG-3Ig增加了DC刺激同种异体T细胞增殖和IFN-γ反应的能力。当使用特异性单克隆抗体连接MHC II类时,未观察到这些效应。由天然配体LAG-3诱导的II类介导的信号导致DC完全成熟,DC获得触发初始T细胞并驱动极化Th1反应的能力。

相似文献

1
Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).淋巴细胞激活基因-3(CD223)诱导树突状细胞的成熟与激活。
J Immunol. 2002 Apr 15;168(8):3874-80. doi: 10.4049/jimmunol.168.8.3874.
2
T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.浸润各种肿瘤类型的T淋巴细胞表达MHC II类配体淋巴细胞激活基因-3(LAG-3):LAG-3/MHC II类相互作用在细胞间接触中的作用。
Eur J Cancer. 2001 Sep;37(13):1709-18. doi: 10.1016/s0959-8049(01)00184-8.
3
Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells.淋巴细胞激活基因-3是一种在活化T细胞上表达的II类主要组织相容性复合体配体,可刺激单核细胞和树突状细胞产生肿瘤坏死因子-α和白细胞介素-12。
J Immunol. 1999 Mar 1;162(5):2748-53.
4
MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells.主要组织相容性复合体II类分子与其配体淋巴细胞激活基因-3(CD223)结合,会导致人树突状细胞呈现出独特的趋化因子和趋化因子受体表达模式。
Vaccine. 2003 Feb 14;21(9-10):862-8. doi: 10.1016/s0264-410x(02)00533-9.
5
Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation.活化T细胞表达的人类淋巴细胞激活基因3分子为树突状细胞激活传递共刺激信号。
J Immunol. 2008 Mar 15;180(6):3782-8. doi: 10.4049/jimmunol.180.6.3782.
6
MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).由天然配体LAG-3蛋白(CD223)诱导的人树突状细胞中的MHC II类信号转导。
Blood. 2003 Sep 15;102(6):2130-7. doi: 10.1182/blood-2003-01-0273. Epub 2003 May 29.
7
Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells.靶向成熟树突状细胞中的抗原以同时刺激CD4+和CD8+ T细胞。
J Immunol. 2001 Apr 15;166(8):5250-7. doi: 10.4049/jimmunol.166.8.5250.
8
LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors.淋巴细胞活化基因3(LAG-3,即CD223)可减少单核细胞前体向巨噬细胞和树突状细胞的分化。
Immunology. 2005 Mar;114(3):369-74. doi: 10.1111/j.1365-2567.2004.02087.x.
9
T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding.T细胞主要组织相容性复合体II类分子在LAG-3结合后下调CD4+ T细胞克隆反应。
Eur J Immunol. 1996 May;26(5):1180-6. doi: 10.1002/eji.1830260533.
10
Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.乌卡瑞替酸 C 联合 IFN-γ 可诱导单核细胞来源的树突状细胞分化,并诱导具有迁移能力的强 Th1 极化。
Cell Immunol. 2010;266(1):104-10. doi: 10.1016/j.cellimm.2010.09.004. Epub 2010 Sep 18.

引用本文的文献

1
A novel mast cell marker gene-related prognostic signature to predict prognosis and reveal the immune landscape in head and neck squamous cell carcinoma.一种用于预测头颈部鳞状细胞癌预后并揭示其免疫格局的新型肥大细胞标志物基因相关预后特征。
Front Immunol. 2025 Jul 9;16:1538641. doi: 10.3389/fimmu.2025.1538641. eCollection 2025.
2
Differential effects of young and old hematopoietic stem cell niches on bone marrow-derived dendritic cells.年轻与老年造血干细胞微环境对骨髓来源树突状细胞的不同影响。
Immun Ageing. 2025 Jul 3;22(1):26. doi: 10.1186/s12979-025-00517-9.
3
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine.
B细胞淋巴瘤免疫治疗的新视野:从免疫检查点到精准医学
Neoplasia. 2025 Jun 30;67:101206. doi: 10.1016/j.neo.2025.101206.
4
The next generation of immunotherapies for lung cancers.肺癌的下一代免疫疗法。
Nat Rev Clin Oncol. 2025 Jun 17. doi: 10.1038/s41571-025-01035-9.
5
Novel immune drug combination induces tumour microenvironment remodelling and reduces the dosage of anti-PD-1 antibody.新型免疫药物组合可诱导肿瘤微环境重塑并降低抗PD-1抗体的剂量。
Sci Rep. 2025 Mar 15;15(1):8956. doi: 10.1038/s41598-025-87344-6.
6
LAG Time in the Era of Immunotherapy-New Molecular Insights Into the Immunosuppression Mechanism of Lymphocyte Activation Gene-3.免疫治疗时代的延迟时间——淋巴细胞激活基因-3免疫抑制机制的新分子见解
Immunol Rev. 2025 Mar;330(1):e70002. doi: 10.1111/imr.70002.
7
The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic Implications.YY1在CD8⁺ T细胞中调控LAG-3表达及癌症免疫逃逸中的作用:治疗意义
Cancers (Basel). 2024 Dec 25;17(1):19. doi: 10.3390/cancers17010019.
8
Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes.肿瘤微环境驱动肿瘤浸润淋巴细胞中共刺激分子与抑制分子之间的相互作用:对优化免疫治疗结果的启示。
Int J Mol Sci. 2024 Nov 29;25(23):12848. doi: 10.3390/ijms252312848.
9
Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy.利用细菌制剂调节肿瘤微环境并增强癌症免疫疗法。
Cancers (Basel). 2024 Nov 13;16(22):3810. doi: 10.3390/cancers16223810.
10
Exploring the molecular landscape of lymphocyte activation gene-3: A literature review.探讨淋巴细胞激活基因-3 的分子图谱:文献综述。
Medicine (Baltimore). 2024 Sep 27;103(39):e39622. doi: 10.1097/MD.0000000000039622.